
Specific bacterial strains show promise in regulating gut inflammation in UC patients.


coremsg

An investigational combination of eight strains of bacteria known collectively as MB310 — a live biotherapeutic product — is due to start its first clinical trial in ulcerative colitis.

Novel Biotherapeutic to Be Tested in Ulcerative Colitis

novel-biotherapeutic-for-ulcerative-colitis-clinical-trial


Novel Biotherapeutic for Ulcerative Colitis Clinical Trial
